InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,049.73
(
0.26%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dubb10

Send PM Follow Ignore
Followers 34
Posts 1982
Boards Moderated 0
Alias Born 01/25/2010

Dubb10

Re: Profit post# 19867

Sunday, 05/01/2016 12:12:19 AM

Sunday, May 01, 2016 12:12:19 AM

Post# of 20775
IMO, the lack of interest has to do with where they are at with their pipeline. For the most part, they are at the preclinical(theory) stage. When they start to test on humans, and can provide substantial proof of concept, then there could be more interest.

Too bad they aren't trying to test cannabinoids on neurological diseases. That would create a lot of interest in the stock, no matter where they are at in the process (esp this year).

My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up